IPHA

Innate Pharma
IPHA

9 hedge funds and large institutions have $731K invested in Innate Pharma in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$191K
2
+$138K
3
+$41.9K
4
UBS Group
UBS Group
Switzerland
+$184

Top Sellers

1
-$140K
2
-$4.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$326K
2
$203K
3
$127K
4
$41.9K
5
$30.5K
6
$1K
7
$604
8
$590
9
$576